Piper Sandler & Co’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-43
Closed -$361K 27
2019
Q2
$361K Buy
+43
New +$361K 0.48% 10